Bruyere Research Institute
Assess the overall acceptability of the 3-drug treatment in the community as compared to the 2-drug treatment
Assess the overall acceptability of the 3-drug treatment in the community as compared to the 2-drug treatment
Developing an appropriate model of care for lymphatic filariasis and leprosy patients who need MMDP services in Bihar State, India
What is the comparative effect of enhancing the existing MMDP services with or without community-based components in significantly reducing the burden of Acute Attacks (AA), Hydrocele, and Mental Health (MH) issues among people affected by LF?
Exploring Patterns of Non-Participation Across Multiple Health Campaigns
1. In areas with low coverage of MDA or a history of never treatment, low coverage for Expanded Programme on Immunization (EPI) vaccines, and/or high malaria prevalence in Ambon City and in Volta Region, Ghana, is never treatment/zero dose a household phenomenon that spans more than one health domain (e.g., neglected tropical diseases, vaccines, insecticide-treated bed net use)?
2. What are the features/traits of households or individuals who miss more than one public health intervention?
3. Does never treatment / zero dose / non-participation vary between public health interventions?
Development of Tools to Re-Orient Social Mobilization Strategies to Close the MDA Coverage-Compliance Gap
To improve compliance and reduce the coverage-compliance gap in mass drug administration through enhanced and tailored social mobilization.
A qualitative exploration to understand the barriers and facilitators related to never treatment during mass drug administration among the migrant and mobile populations in Mali
|
Primary Research Question: To explore the reasons behind never treatment during PC-NTDs MDA in Mali and provide evidence to support the development of an effective programmatic response, including a further quantitative assessment of the factors associated with never treatment and recommendations for qualitative assessments of never treatment. |
|
Secondary Research Question:
The NTD program in Mali has been highly affected by growing conflict and regional instability over the past five years. Earlier research supported by COR-NTD (200D Mali) indicated that 12% of nomads and other mobile populations were never treated during MDA with more than 35% of the participants stating that they did not participate in the last MDA campaign. The study team proposes conducting 12 focus groups and 24 in-depth interviews with a variety of mobile populations and health care workers in two health districts of Mali: Tominian and Kalaban-coro. The mobile populations are divided into three categories: economic migrants, internally displaced persons, and nomads. Following this formative research, the study team aims to draft and pilot a standardized, closed-ended question on reasons for NT for inclusion in programmatic questionnaires and surveys. They also aim to use this research as a springboard to develop a rapid qualitative assessment for never treatment in mobile populations. |
Sustaining the Gains of NTD elimination programs through focused support of community drug distributors
To sustain the gains of active community drug distributors (CDDs) by enhancing their performance through intervention at the individual, community and primary health care center levels to reach NTD elimination and control goals.
Development of Tools to Re-Orient Social Mobilization Strategies to Close the MDA Coverage-Compliance Gap
To improve compliance and reduce the coverage-compliance gap in mass drug administration through enhanced and tailored social mobilization.
Understanding the factors that motivate and sustain community drug distributors in the changing context of NTD control and elimination
How do we motivate community drug distributors (CDDs)?
A qualitative exploration to understand the barriers and facilitators related to never treatment during mass drug administration among the migrant and mobile populations in Mali
|
Primary Research Question: To explore the reasons behind never treatment during PC-NTDs MDA in Mali and provide evidence to support the development of an effective programmatic response, including a further quantitative assessment of the factors associated with never treatment and recommendations for qualitative assessments of never treatment. |
|
Secondary Research Question:
The NTD program in Mali has been highly affected by growing conflict and regional instability over the past five years. Earlier research supported by COR-NTD (200D Mali) indicated that 12% of nomads and other mobile populations were never treated during MDA with more than 35% of the participants stating that they did not participate in the last MDA campaign. The study team proposes conducting 12 focus groups and 24 in-depth interviews with a variety of mobile populations and health care workers in two health districts of Mali: Tominian and Kalaban-coro. The mobile populations are divided into three categories: economic migrants, internally displaced persons, and nomads. Following this formative research, the study team aims to draft and pilot a standardized, closed-ended question on reasons for NT for inclusion in programmatic questionnaires and surveys. They also aim to use this research as a springboard to develop a rapid qualitative assessment for never treatment in mobile populations. |